Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

Background: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. Methods: Thus, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Joyner, Michael, Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon, Bruno, Katelyn, Klassen, Stephen, Carter, Rickey, Klompas, Allan, Wiggins, Chad, Shepherd, John RA, Rea, Robert, Whelan, Emily, Clayburn, Andrew, Spiegel, Matthew, Johnson, Patrick, Lesser, Elizabeth, Baker, Sarah, Larson, Kathryn, Ripoll Sanz, Juan, Andersen, Kylie, Hodge, David, Kunze, Katie, Buras, Matthew, Vogt, Matthew, Herasevich, Vitaly, Dennis, Joshua, Regimbal, Riley, Bauer, Philippe, Blair, Janis, van Buskirk, Camille, Winters, Jeffrey, Stubbs, James, Paneth, Nigel, Casadevall, Arturo
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274247/
https://ncbi.nlm.nih.gov/pubmed/32511566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.12.20099879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados